Full-year report on Innate Pharma’s liquidity contract with Gilbert Dupont

January 8, 2015 at 8:00 AM EST

Under the liquidity contract entrusted by Innate Pharma to Gilbert Dupont, the following assets appeared on the liquidity account as at December 31, 2014:
-    33,310 shares of Innate Pharma, and
-    233,366.36 euros in cash

As a reminder, at June 30, 2014, the following assets appeared on the liquidity account:
-    23,490 shares of Innate Pharma, and
-    312,376.44 euros in cash